propranolol has been researched along with salmeterol xinafoate in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (52.38) | 18.2507 |
| 2000's | 5 (23.81) | 29.6817 |
| 2010's | 3 (14.29) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, JG | 1 |
| Charlton, SJ; Dickson, CJ; Duca, JS; Fairhurst, RA; Hornak, V; McKay, DJ; Pearlstein, RA; Reilly, J; Sandham, DA; Shaw, D; Sykes, DA; Velez-Vega, C | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Davies, RJ; Devalia, JL; Rusznak, C; Sapsford, RJ; Toumbis, MJ | 1 |
| Ball, DI; Brittain, RT; Coleman, RA; Denyer, LH; Jack, D; Johnson, M; Lunts, LH; Nials, AT; Sheldrick, KE; Skidmore, IF | 1 |
| Butchers, PR; Johnson, M; Vardey, CJ | 1 |
| Bindi, D; Gentilini, G; Grazia di Bello, M; Mugnai, S; Raspanti, S; Zilletti, L | 1 |
| Baker, AJ; Fuller, RW; Johnson, M; Palmer, J | 1 |
| Hellewell, PG; Teixeira, MM; Williams, TJ | 1 |
| Jeppsson, AB; Nilsson, E; Waldeck, B | 1 |
| Grove, A; Lipworth, BJ | 1 |
| Bake, B; Bergendal, A; Johansson, A; Löfdahl, CG; Lötvall, J; Skoogh, BE | 1 |
| Gonsiorek, W; Kavaler, JP; Maayani, S; Schachter, EN; Sugár, IP; Wachsman, DE | 1 |
| Dekhuijzen, PN; Folgering, H; Heunks, LM; van der Heijden, HF; van Herwaarden, CL | 1 |
| Dextradeur, T; Ethier, MF; Madison, JM; Schaefer, OP | 1 |
| Christian, C; Kresch, MJ; Kumar, VH | 1 |
| Eliseeva, EV | 1 |
| Carter, AA; Hill, SJ | 1 |
| Alizadeh, AM; Ansari Pirsaraie, Z; Atashnak, MP; Hatefi, A; Masoudi, R; Pio, F; Zare Shahneh, A | 1 |
| Ali, A; Emran, TB; Imran, M; Ismail, ISB; Latif, Z; Muhammad, N; Saeed, L; Safi, SZ; Shah, H; Subramaniyan, V | 1 |
2 trial(s) available for propranolol and salmeterol xinafoate
| Article | Year |
|---|---|
Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
Topics: Adrenergic Agents; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Albuterol; Bronchodilator Agents; Cross-Over Studies; Ethanolamines; Exercise; Female; Formoterol Fumarate; Heart Rate; Humans; Male; Potassium; Propranolol; Salmeterol Xinafoate; Single-Blind Method; Tremor | 1996 |
Airway effects of salmeterol in healthy individuals.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Albuterol; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Male; Muscle Relaxation; Muscle, Smooth; Propranolol; Salmeterol Xinafoate | 1995 |
19 other study(ies) available for propranolol and salmeterol xinafoate
| Article | Year |
|---|---|
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Uncoupling the Structure-Activity Relationships of β2 Adrenergic Receptor Ligands from Membrane Binding.
Topics: Binding Sites; Cell Membrane; Dose-Response Relationship, Drug; Humans; Ligands; Models, Molecular; Molecular Structure; Receptors, Adrenergic, beta-2; Structure-Activity Relationship | 2016 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The effects of salmeterol and salbutamol on ciliary beat frequency of cultured human bronchial epithelial cells, in vitro.
Topics: Adrenergic beta-Agonists; Albuterol; Bronchi; Cells, Cultured; Cilia; Drug Interactions; Epithelium; Humans; Propranolol; Salmeterol Xinafoate | 1992 |
Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Bronchodilator Agents; Dinoprost; Electric Stimulation; Guinea Pigs; Humans; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Muscle, Smooth; Propranolol; Rats; Salmeterol Xinafoate; Stomach; Trachea | 1991 |
Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung.
Topics: Adrenergic beta-Agonists; Albuterol; Histamine Release; Humans; Hypersensitivity; In Vitro Techniques; Inflammation; Lung; Mast Cells; Propranolol; Prostaglandin D2; Salmeterol Xinafoate; SRS-A | 1991 |
Salmeterol inhibits anaphylactic histamine release from guinea-pig isolated mast cells.
Topics: Adrenergic beta-Agonists; Albuterol; Anaphylaxis; Animals; Fluorometry; Guinea Pigs; Histamine Antagonists; Histamine Release; In Vitro Techniques; Male; Mast Cells; Peritoneal Cavity; Pleura; Propranolol; Salmeterol Xinafoate | 1994 |
Inhibitory actions of salmeterol on human airway macrophages and blood monocytes.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Albuterol; Analysis of Variance; Bronchoalveolar Lavage Fluid; Bronchodilator Agents; Calcimycin; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Isoproterenol; Macrophages, Alveolar; Monocytes; Propranolol; Salmeterol Xinafoate; Sodium Fluoride; Thromboxane B2; Zymosan | 1994 |
Anti-inflammatory effects of a short-acting and a long-acting beta 2-adrenoceptor agonist in guinea pig skin.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Animals; Anti-Inflammatory Agents, Non-Steroidal; Eosinophils; Guinea Pigs; Male; Passive Cutaneous Anaphylaxis; Propranolol; Salmeterol Xinafoate; Skin | 1995 |
Formoterol and salmeterol are both long acting compared to terbutaline in the isolated perfused and ventilated guinea-pig lung.
Topics: Acetylcholine; Administration, Inhalation; Albuterol; Analysis of Variance; Animals; Bronchoconstriction; Bronchodilator Agents; Electrophysiology; Ethanolamines; Formoterol Fumarate; Guinea Pigs; In Vitro Techniques; Lung; Male; Propranolol; Pulmonary Artery; Salmeterol Xinafoate; Terbutaline | 1994 |
Kinetic studies of desensitization and resensitization of the relaxation response to beta-2 adrenoceptor agonists in isolated guinea pig trachea.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Animals; Carbachol; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Potassium Chloride; Propranolol; Salmeterol Xinafoate; Trachea | 1997 |
beta2-adrenoceptor agonists reduce the decline of rat diaphragm twitch force during severe hypoxia.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Diaphragm; Hypoxia; In Vitro Techniques; Male; Muscle Contraction; Propranolol; Rats; Rats, Wistar; Salmeterol Xinafoate | 1999 |
Effects of salmeterol on muscarinic inhibition of adenylyl cyclase in bovine trachealis cells.
Topics: 1-Methyl-3-isobutylxanthine; Adenylyl Cyclase Inhibitors; Adrenergic beta-Agonists; Albuterol; Animals; Cattle; Cyclic AMP; Dinoprostone; Kinetics; Muscarinic Antagonists; Propranolol; Receptors, Muscarinic; Salmeterol Xinafoate; Trachea | 2000 |
Effects of salmeterol on secretion of phosphatidylcholine by alveolar type II cells.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Epithelial Cells; L-Lactate Dehydrogenase; Male; Phosphatidylcholines; Propranolol; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Salmeterol Xinafoate | 2000 |
[Inducible nitric oxide synthase in rat lungs in experimental bronchial asthma and its status in administering drugs with adrenergic action].
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Asthma; Fenoterol; Lung; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Propranolol; Rats; Salmeterol Xinafoate | 2002 |
Characterization of isoprenaline- and salmeterol-stimulated interactions between beta2-adrenoceptors and beta-arrestin 2 using beta-galactosidase complementation in C2C12 cells.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Arrestins; beta-Arrestin 2; beta-Arrestins; beta-Galactosidase; Cell Line; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Genetic Complementation Test; Humans; Isoproterenol; Mutation; Propanolamines; Propranolol; Receptors, Adrenergic, beta-2; Recombinant Fusion Proteins; Salmeterol Xinafoate; Transfection | 2005 |
The stimulation and inhibition of beta-2 adrenergic receptor on the inflammatory responses of ovary and immune system in the aged laying hens.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Antagonists; Androgens; Animals; Chickens; Cytokines; Enzyme-Linked Immunosorbent Assay; Estradiol; Female; Immune System; Immunity, Cellular; Immunity, Humoral; Inflammation Mediators; Ovary; Progesterone; Propranolol; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate | 2021 |
Mechanisms of β-adrenergic receptors agonists in mediating pro and anti-apoptotic pathways in hyperglycemic Müller cells.
Topics: Adrenergic beta-Agonists; Brain-Derived Neurotrophic Factor; Caspase 3; Caspase 8; Cyclic AMP Response Element-Binding Protein; Cytochromes c; Ependymoglial Cells; Glucose; Humans; Isoproterenol; Propranolol; Reactive Oxygen Species; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Xamoterol | 2022 |